🇺🇸 FDA
Pipeline program

Gynaecological follow-up

112024

Phase 3 other completed

Quick answer

Gynaecological follow-up for Infections, Papillomavirus is a Phase 3 program (other) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline
Indication
Infections, Papillomavirus
Phase
Phase 3
Modality
other
Status
completed

Clinical trials